Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3019343 | Revista Española de Cardiología Suplementos | 2015 | 6 Pages |
Abstract
Statins are drugs that reduce the plasma low-density lipoprotein cholesterol level. They have been shown to be effective for both primary and secondary cardiovascular prevention. These drugs can be classified according to their lipid-lowering capacity and are considered to have a high potency or high intensity if they can reduce levels by approximately 50%. In addition, they have other effects that do not appear to be explained solely by their ability to reduce the cholesterol level. It is thought these effects are related to other properties of the drugs (e.g. their antioxidant, anti-inflammatory or antithrombotic properties) which are associated with their actions on G proteins. These extralipid effects have been studied in various cardiovascular diseases and in other conditions, such as sepsis, cancer and dementia. However, existing data are not clear enough to justify extending the therapeutic indications of statins beyond cholesterol reduction.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Pilar Mazón Ramos,